Jolessa

Pregnancy Prevention

Jolessa is primarily used as a hormonal method of birth control to prevent pregnancy. It contains a combination of two female hormones, an estrogen and a progestin, which work together to inhibit ovulation (the release of an egg from an ovary). It also causes changes in the cervical mucus and uterine lining, making it more difficult for sperm to reach the egg or for a fertilized egg to implant.

Extended-Cycle Regimen

This medication is specifically designed as an extended-cycle contraceptive. While traditional birth control pills often follow a 28-day cycle with monthly bleeding, Jolessa follows a 91-day cycle. This approach is used for:

• Reducing the total number of menstrual periods per year.
• Managing menstruation-related symptoms by providing a more consistent hormone level over a longer period.

Because of this schedule, users typically experience a scheduled period once every three months (during the 13th week of the cycle) rather than once every month. It is important to note that while Jolessa prevents pregnancy, it does not protect against HIV infection or other sexually transmitted diseases.

Hormonal Action

Jolessa contains two types of female hormones: a progestin (levonorgestrel) and an estrogen (ethinyl estradiol). These hormones work together to prevent pregnancy through several different methods:

• Stopping Ovulation: The primary way this medication works is by preventing the ovaries from releasing an egg each month. Without an egg, fertilization cannot occur.
• Thickening Cervical Mucus: The hormones cause the mucus in the cervix to become thicker. This makes it much more difficult for sperm to travel through the cervix and reach the uterus.
• Changing the Uterine Lining: The medication alters the lining of the uterus (endometrium). This change makes it less likely for a fertilized egg to attach to the uterine wall.

Extended Cycle Delivery

Unlike traditional birth control pills that follow a 28-day cycle, Jolessa is designed as an extended-cycle regimen. It provides a continuous dose of active hormones for 84 days, followed by 7 days of inactive pills. This schedule is intended to reduce the frequency of menstrual periods to once every three months while maintaining consistent pregnancy prevention.

Common Side Effects

Many people using Jolessa experience mild side effects as their bodies adjust to the medication. These may include:

• Nausea, vomiting, or stomach cramps
• Bloating or weight changes
• Headache or nervousness
• Breast tenderness or enlargement
• Vaginal itching or discharge
• Changes in menstrual periods, including breakthrough bleeding and spotting between periods
• Decreased sex drive
• Acne or darkening of facial skin

Serious Side Effects

While less common, Jolessa can cause serious health problems. Seek medical attention immediately if you experience:

• Signs of a blood clot, such as sudden shortness of breath, chest pain, or swelling and warmth in one leg
• Symptoms of a stroke, including sudden numbness or weakness, severe headache, or vision changes
• Liver problems, such as yellowing of the eyes or skin (jaundice), dark urine, or upper stomach pain
• New or worsening depression or mood changes
• A sudden increase in blood pressure
• Signs of a severe allergic reaction, such as hives, difficulty breathing, or swelling of the face and throat

Boxed Warning: Smoking and Cardiovascular Risk

Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use. This risk increases with age and with the number of cigarettes smoked. This risk is particularly high in women over 35 years of age. Combination oral contraceptives, including Jolessa, are contraindicated in women who are over 35 years old and smoke.

Vascular Risks

The use of combination oral contraceptives is associated with an increased risk of several serious vascular conditions, including:

• Blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism)
• Heart attack (myocardial infarction)
• Stroke

The risk of these events is further increased in individuals with other risk factors such as high blood pressure, high cholesterol, obesity, or diabetes.

Contraindications

Jolessa should not be used by individuals with certain health conditions, such as:

• A history of blood clots or circulatory disorders
• Current or past breast cancer or other estrogen-sensitive cancers
• Severe high blood pressure
• Liver tumors (benign or malignant) or active liver disease
• Migraine headaches with aura
• Undiagnosed abnormal vaginal bleeding
• Pregnancy

Additional Precautions

Liver Health: Discontinue use if jaundice (yellowing of the skin or eyes) develops. Combination oral contraceptives may be associated with an increased risk of liver tumors, though this is rare.

High Blood Pressure: Blood pressure should be monitored regularly, as some users may experience significant increases.

Gallbladder Disease: Some studies suggest an increased risk of gallbladder disease in users of oral contraceptives.

Glucose Tolerance: Jolessa may affect blood sugar levels. Individuals with diabetes or prediabetes should be monitored closely while using this medication.

Bleeding Patterns: Because Jolessa is an extended-cycle contraceptive, breakthrough bleeding and spotting are common, especially during the first few cycles. If bleeding is unusually heavy or persistent, medical evaluation may be necessary.

Pregnancy

Jolessa should not be used during pregnancy. If you become pregnant while taking this medication, you should stop taking it immediately. Research involving women who accidentally used oral contraceptives during early pregnancy has not shown an increased risk of birth defects or other harmful effects on the developing fetus.

Breastfeeding

The hormones in Jolessa can pass into breast milk in small amounts. Use of combined oral contraceptives while breastfeeding may lead to the following:

• A decrease in the quantity of breast milk produced.
• A change in the nutritional quality of the milk.

It is generally recommended to use other forms of contraception until the infant is completely weaned. Discussing contraceptive options with a healthcare provider can help determine the best approach for your specific situation.

Dosage Forms

Jolessa is supplied as tablets for oral administration. The medication is organized in a blister card that includes two different types of tablets:

• Active tablets: These are round, film-coated tablets that contain the active hormonal medication.
• Inert tablets: These are round tablets that do not contain active medication, used to complete the dosing cycle.

FDA Approval and Indications

Jolessa is approved by the U.S. Food and Drug Administration (FDA) as a combination oral contraceptive. It is specifically indicated for the prevention of pregnancy in women who choose to use oral medication as a method of contraception.

Boxed Warning

The FDA-approved labeling for Jolessa includes a boxed warning regarding cigarette smoking and serious cardiovascular events. This is the most serious type of warning required by the FDA. Key safety information includes:

• Increased Risk: Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use.
• Age and Smoking: This risk increases with age, particularly in women over 35 years old, and with the number of cigarettes smoked.
• Contraindication: Because of these risks, combination oral contraceptives like Jolessa should not be used by women who are over 35 years of age and smoke.

Regulatory Status

Jolessa is a prescription-only medication. It is an extended-cycle regimen, providing 84 days of active hormones followed by 7 days of inactive tablets. This schedule is designed to reduce the frequency of scheduled menstrual periods to once every three months. It is not a controlled substance and does not currently have a Risk Evaluation and Mitigation Strategy (REMS) program.

Weight Changes and Jolessa

Weight gain is a recognized potential side effect of Jolessa. Clinical studies and medical literature indicate that hormonal contraceptives can lead to changes in body weight for some users.

Reported Frequency

• During clinical trials of Jolessa, weight increase was reported by approximately 2% of participants.
• While weight gain is more frequently noted, some users may experience weight loss or no change in weight at all.

Potential Causes

Several factors related to hormonal birth control may contribute to a change in weight:

• Fluid Retention: The estrogen component in Jolessa may cause the body to retain extra fluid, which can result in bloating or a minor increase in weight.
• Metabolic Changes: Hormonal shifts can sometimes influence appetite or how the body processes certain nutrients.

If weight changes become a concern or are accompanied by other symptoms, it is recommended to speak with a healthcare provider to evaluate the cause and discuss management options.